Profile picture

Professor Martin Haluzik

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)
Follow
Biography
Martin Haluzík is a Professor of Internal Medicine, Director of the Diabetes Centre of the Institute for Clinical and Experimental Medicine in Prague and Head of the Metabolic Research Group at the Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Charles University, Prague. Professor Haluzík’s main areas of clinical expertise include diabetology, obesitology and general internal medicine. The major focus of his research concerns the aetiopathogenesis of obesity, insulin resistance and type 2 and type 1 diabetes. Professor Haluzík has special interests in the endocrine function of adipose tissue, the incretin system, novel hormonal factors involved in the regulation of energy homeostasis and glucose metabolism, and the use of novel technologies and therapeutics in the treatment of diabetes. He has been a global expert panel member and national leader for numerous clinical trials with novel antidiabetic drugs.
Logo ESC

Contributor content

Artificial intelligence to redefine metabolic risk assessment
Presentation
Artificial intelligence to redefine metabolic risk assessment